{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:56:34Z","timestamp":1762505794439},"reference-count":77,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1492,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1756-185x.2011.01626.x","type":"journal-article","created":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T05:11:11Z","timestamp":1312521071000},"page":"223-238","source":"Crossref","is-referenced-by-count":19,"title":["Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines"],"prefix":"10.1111","volume":"14","author":[{"given":"Julie","family":"LI-YU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel C.","family":"PEREZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"CA\u00d1ETE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauro","family":"BONIFACIO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndon Q.","family":"LLAMADO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romil","family":"MARTINEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"LANZON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mae","family":"SISON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Osteoporosis Society of the Philippines Foundation, Inc. (OSPFI) and Philippine Orthopedic Association (POA) Clinical Practice Guidelines Task Force Committee on Osteoporosis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB1|cit1","doi-asserted-by":"crossref","unstructured":"Chuzeau F Burgers J 2003 Appraisal of guidelines for research & evaluation instrument (AGREE) January 2003 http:\/\/www.agreecollaboration.org","DOI":"10.1037\/t29531-000"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations (GRADES)","volume":"328","author":"Grade Working Group","year":"2004","journal-title":"Br Med J"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/S1701-2163(16)32087-4","article-title":"Canadian Consensus Conference on osteoporosis, 2006 Update","volume":"172","author":"Brown","year":"2006","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB5|cit5","unstructured":"Ministry of Health Clinical Practice Guidelines Osteoporosis 2002"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.gme.0000222475.93345.b3","article-title":"Management of osteoporosis in postmenopausal women: 2006 Position statement of the North American Menopause Society","volume":"13","author":"North American Menopause Society","year":"2006","journal-title":"Menopause"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB7|cit7","first-page":"1","volume-title":"Management of Osteoporosis A National Clinical Guideline 2003","author":"Scottish Intercollegiate Guidelines Network","year":"2003"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jocd.2007.12.007","article-title":"Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference","volume":"11","author":"Baim","year":"2008","journal-title":"J Clin Densitom"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","article-title":"Position Paper European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"volume-title":"Expert Panel on Musculoskeletal Imaging. Osteoporosis and Bone Mineral Density","year":"2007","author":"Richmond","key":"10.1111\/j.1756-185X.2011.01626.x-BIB10|cit10"},{"volume-title":"Prevention of Hip Fracture Amongst People Aged 65 Years and Over","year":"2003","author":"New Zealand Guidelines Group (NZGG)","key":"10.1111\/j.1756-185X.2011.01626.x-BIB11|cit11"},{"volume-title":"EBM Guidelines. Evidence-Based Medicine","year":"2006","author":"Finnish Medical Society Duodecim","key":"10.1111\/j.1756-185X.2011.01626.x-BIB12|cit12"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.gme.0000243566.25205.0b","article-title":"Role of calcium in peri- and postmenopausal women: 2006 position statement of The North American Menopause Society","volume":"13","author":"Heaney","year":"2006","journal-title":"Menopause"},{"volume-title":"Exercise Promotion: Walking in Elders","year":"2007","author":"Jitramontree","key":"10.1111\/j.1756-185X.2011.01626.x-BIB14|cit14"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003","volume":"9","author":"Hodgson","year":"2003","journal-title":"Endocr Pract"},{"volume-title":"Bisphosphonates, Selective Estrogen Receptor Modulator, Parathyroid Hormone for the Secondary Prevention of Osteoporotic Fragility Fractures in Postmenopausal Women","year":"2005","author":"National Institute for Clinical Excellence","key":"10.1111\/j.1756-185X.2011.01626.x-BIB16|cit16"},{"volume-title":"Diagnosis and Treatment of Osteoporosis","year":"2006","author":"Institute for Clinical Systems Improvement (ICSI)","key":"10.1111\/j.1756-185X.2011.01626.x-BIB17|cit17"},{"volume-title":"Osteoporosis: Prevention and Treatment","year":"2005","author":"University of Michigan Health System","key":"10.1111\/j.1756-185X.2011.01626.x-BIB18|cit18"},{"volume-title":"Recommended Energy and Nutrient Intakes Philippines, 2002 Edition","year":"2002","author":"Food and Nutrition Research Institute, Department of Science and Technology","key":"10.1111\/j.1756-185X.2011.01626.x-BIB19|cit19"},{"issue":"Issue 1","key":"10.1111\/j.1756-185X.2011.01626.x-BIB20|cit20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004526.pub2","article-title":"Calcium supplementation on bone loss in postmenopausal women","author":"Shea","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"Issue 2","key":"10.1111\/j.1756-185X.2011.01626.x-BIB21|cit21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000227.pub3","article-title":"Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal women (review)","author":"Avenell","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.apmr.2007.02.012","article-title":"The effects of Tai Chi on bone mineral density in postmenopausal women. A systematic review","volume":"88","author":"Wayne","year":"2007","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB23|cit23","first-page":"130","article-title":"Tai Chi for osteoporosis: a systematic review","volume":"19","author":"Lee","year":"2008","journal-title":"Osteopors Int"},{"issue":"Issue 2","key":"10.1111\/j.1756-185X.2011.01626.x-BIB24|cit24","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000333","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","author":"Bonaiuti","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00198-006-0083-4","article-title":"High intensity resistance training and postmenopausal bone loss: a meta-analysis","volume":"17","author":"Martyn-St James","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/aje\/kwg265","article-title":"Weight loss: a determinant of hip bone loss n older men and women","volume":"158","author":"Knoke","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archinte.161.7.983","article-title":"Cigarette smoking, alcohol consumption, and risk of hip fracture in women","volume":"161","author":"Baron","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.maturitas.2009.03.002","article-title":"The role of physical activity in the prevention of osteoporosis in postmenopausal women - an update","volume":"63","author":"Schmitt","year":"2009","journal-title":"Maturitas"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1001\/jama.288.18.2300","article-title":"Walking and leisure time activity and risk of hip fracture in postmenopausal women","volume":"288","author":"Feskanich","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1001\/archinte.165.16.1890","article-title":"Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women","volume":"165","author":"Zhang","year":"2005","journal-title":"Arch Int Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1210\/jc.2003-030290","article-title":"Soy isoflavones have favorable effect on bone loss in Chinese postmenppausal women ith lower bone mass: a double-blind randomized controlled trial","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00198-005-1929-x","article-title":"Validation of OSTA among Filipinos","volume":"16","author":"Li-Yu","year":"2005","journal-title":"Osteoporos Int"},{"volume-title":"Assessment of Osteoporosis at the Primary Health Care Level","year":"2008","author":"Kanis","key":"10.1111\/j.1756-185X.2011.01626.x-BIB33|cit33"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s11547-008-0294-1","article-title":"Detection of incidental vertebral fractures on routine hest radiographs","volume":"113","author":"Cataldi","year":"2008","journal-title":"Radiol Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jocd.2009.02.002","article-title":"2008 Sta. Fe Bone Symposium: update on osteoporosis. Assessment of Skeletal Health","volume":"12","author":"Lewiecki","year":"2009","journal-title":"J Clin Densitom"},{"volume-title":"National Osteoporosis Foundation Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis","year":"2008","author":"National Osteoporosis Foundation","key":"10.1111\/j.1756-185X.2011.01626.x-BIB37|cit37"},{"issue":"Issue 1","key":"10.1111\/j.1756-185X.2011.01626.x-BIB38|cit38","article-title":"Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women (review)","author":"Wells","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/er.2001-2002","article-title":"Meta-analysis of therapies for postmenopausal women. II. Meta-analysis of alendronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"issue":"Issue 1","key":"10.1111\/j.1756-185X.2011.01626.x-BIB40|cit40","article-title":"Risedronate for the primary and secondary prevetion of osteoporotic fractures in postmenopausal women","author":"Wells","year":"2008","journal-title":"Cochrane Databse Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1210\/er.2001-3002","article-title":"Meta-analysis of therapies for postmenopausal women. III. Meta-analysis of risedronate for the treatment of postmenopausal women","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s00198-004-1602-9","article-title":"Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study","volume":"15","author":"Delmas","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-008-0653-8","article-title":"Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data","volume":"20","author":"Cranney","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women ith low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once yearly zoledronic acid or treatment of postmenopausal women","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00198-005-2030-1","article-title":"Anti-vertebral fracture efficacy of raloxifene: a meta-analysis","volume":"17","author":"Seeman","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/er.2001-4002","article-title":"Meta-analysis of therapies for postmenopausal women. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"issue":"Issue 4","key":"10.1111\/j.1756-185X.2011.01626.x-BIB48|cit48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005326.pub2","article-title":"Strontium ranelate for preventing and treating postmenopausal osteoporosis","author":"O\u2019Donnell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1359\/jbmr.071105","article-title":"Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia","volume":"23","author":"Seeman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analysis of therapies for postmenopausal women. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women","volume":"23","author":"Wells","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group","volume":"109","author":"Chestnut","year":"2000","journal-title":"Am J Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00223-001-2111-x","article-title":"Randomized double blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture","volume":"71","author":"Huusko","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone inolder postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"issue":"Issue 3","key":"10.1111\/j.1756-185X.2011.01626.x-BIB54|cit54","first-page":"CD001255","article-title":"Hip protectors for preventing hip fractures in older people","author":"Parker","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/aje\/155.7.636","article-title":"Protein consumption and bone mineral density in the elderly. The Rancho Bernardo Study","volume":"55","author":"Promislow","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"Issue 4","key":"10.1111\/j.1756-185X.2011.01626.x-BIB56|cit56","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001880.pub4","article-title":"Nutritional supplementation for hip fracture aftercare in older people","author":"Avenell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/sj.ejcn.1601623","article-title":"A systematic review of protein and energy supplementation for hip fracture aftercare in older people","volume":"57","author":"Avenell","year":"2003","journal-title":"Eur J Clin Nutr"},{"issue":"Issue 4","key":"10.1111\/j.1756-185X.2011.01626.x-BIB58|cit58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004963.pub2","article-title":"Exercise for improving balance in older people","author":"Howe","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","article-title":"Effect of recombinant human parathyroid (1-84)hormone on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double blind trial to compare the efficacy of teriparatide [Recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2003-030768","article-title":"Efficacy and safety of human parathyroid hormone (1-84) in increasing bone mineral density of postmenopausal osteoporosis","volume":"88","author":"Hodsman","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/ard.2008.094516","article-title":"Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis","volume":"67","author":"Roux","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.23461","article-title":"Effects of long term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a 5-year, randomized, placebo-controlled trial","volume":"58","author":"Reginster","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.bone.2009.08.004","article-title":"Long term treatment of postmenopausal women with strontium ranelate: results at 8\u2003years","volume":"45","author":"Reginster","year":"2009","journal-title":"Bone"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00223-008-9152-3","article-title":"Parathryoid (1-84) treatment of postemenopausal women with low bone mass receving hormone replacement therapy","volume":"83","author":"Fogelman","year":"2008","journal-title":"Calc Tissue Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2007-0711","article-title":"Effects of previous antiresoprtive therapy on the bone mineral density response to 2\u2003years of teriparatide treatment in postmenppausal women with osteoporosis","volume":"93","author":"Boonen","year":"2008","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00223-007-9066-5","article-title":"The effect of prior bisphosphonate exposure on the treatment response to teriparatide in clinical practice","volume":"81","author":"Middleton","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5435\/00124635-200810000-00005","article-title":"Surgical management of hip fractures: an evidence-based review of the literature. I: femoral neck fractures","volume":"16","author":"Miyamoto","year":"2008","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5435\/00124635-200811000-00007","article-title":"Surgical management of hip fractures: an evidence-based review of the literature II: intertrochanteric fractures","volume":"16","author":"Kevin","year":"2008","journal-title":"J Am Orthop Surg"},{"issue":"14","key":"10.1111\/j.1756-185X.2011.01626.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1001\/jama.291.14.1738","article-title":"Association of timing of surgery for hip fracture and patient outcomes","volume":"291","author":"Orosz","year":"2004","journal-title":"JAMA"},{"volume-title":"Management of Hip Fracture in Older People: A National Clinical Guideline","year":"2009","author":"Scottish Intercollegiate Guidelines Network (SIGN)","key":"10.1111\/j.1756-185X.2011.01626.x-BIB73|cit73"},{"issue":"Issue 3","key":"10.1111\/j.1756-185X.2011.01626.x-BIB74|cit74","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000168.pub2","article-title":"Pre-operative traction for fractures of the proximal femur in adults","author":"Parker","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.ta.0000214649.53190.2a","article-title":"Is the delay to surgery for isolated hip fracture predictive of outcome in efficient systems?","volume":"60","author":"Bergeron","year":"2006","journal-title":"J Trauma"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1359\/jbmr.2000.15.3.586","article-title":"The effect of alendronate on bone mass after distal forearm fracture","volume":"15","author":"Van der Poest Clement","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1111\/j.1756-185X.2011.01626.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1359\/jbmr.2002.17.12.2247","article-title":"Alendronate in the prevention of bone loss after a fracture of the lower leg","volume":"17","author":"Van Der Poest Clement","year":"2002","journal-title":"J Bone Miner Res"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1756-185X.2011.01626.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1756-185X.2011.01626.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T14:21:48Z","timestamp":1638195708000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1756-185X.2011.01626.x"}},"subtitle":["Position statements on osteoporosis"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1756-185x.2011.01626.x","relation":{},"ISSN":["1756-1841"],"issn-type":[{"type":"print","value":"1756-1841"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}